Cellular senescence enhances adaptive anticancer immunosurveillance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cellular senescence enhances adaptive anticancer immunosurveillance

Published:2022-12-15 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Marin Ines¹^ORCID,Serrano Manuel¹²^ORCID,Pietrocola Federico³^ORCID

Affiliation:

1. Aging and Metabolism Programme, Institute for Research in Biomedicine (IRB), Barcelona Institute of Science and Technology, Barcelona 08028, Spain

2. Catalan Institution for Research and Advanced Studies, Barcelona 08010, Spain

3. Department of Biosciences and Nutrition, Karolinska Institute, Huddinge 14157, Sweden

Funder

funding

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2154115

Reference10 articles.

1. Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity

2. Oncology Meets Immunology: The Cancer-Immunity Cycle

3. Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology

4. Cellular Senescence: Defining a Path Forward

5. Type I interferons and endoplasmic reticulum stress in health and disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Interplay between Cellular Senescence, Immunity, and Fibrosing Interstitial Lung Diseases: Challenges and Opportunities;International Journal of Molecular Sciences;2024-07-10

2. Senescent cell-derived vaccines: a new concept towards an immune response against cancer and aging?;Aging;2024-06-26

3. METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer;Cancer Letters;2024-04

4. Cellular senescence and aging at the crossroad between immunity and cancer;Methods in Cell Biology;2024

5. Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma;Clinical Cancer Research;2023-09-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3